세계의 피부과 진단 분야 인공지능(AI) 시장 : 예측(2024-2029년)

The Artificial Intelligence (AI) in the dermatology diagnosis market is expected to grow at a CAGR of 25.43%, reaching a market size of US$630.883 million in 2029 from US$203.208 million in 2024.

The demand for AI-based dermatology diagnosis services is expected to grow steadily. AI in dermatology diagnosis is set to transform dermatological services, i.e., AI will be applied to diagnose and treat dermatological conditions. The situation becomes worse as skin diseases are rising worldwide, thus increasing the demand for quick and precise diagnosis. Dermatological systems that use AI technology explore vast repositories of medical images through sophisticated algorithms for faster and more effective diagnosis and classification of skin issues. These technologies enable dermatologists to provide more accurate diagnoses, enhancing treatment methods and successful healthcare results tailored to individual patients. As technological developments escalate, the demand for AI in dermatology diagnosis is expected to grow tremendously, offering a better treatment option for dermatological services and increasing the management scope of skin diseases.

Artificial Intelligence (AI) in Dermatology Diagnosis Market Drivers:

• Increasing prevalence of skin disorders enhances the AI in dermatology diagnosis market growth

The market for AI in dermatology diagnosis is growing significantly due to the increased prevalence of skin-related issues globally. Skin disorders, as the World Health Organisation (WHO) points out, affect the lives of most people, and an estimated 900 million people have skin diseases at any time. Health conditions like acne, psoriasis, and malignant skin tumors are serious public health issues and require an accurate and timely diagnosis. Using AI in dermatology to analyze large amounts of clinical photographs, such advanced dermatological solutions assist healthcare experts in formulating a more accurate diagnosis. With the rising occurrence of skin disorders, the emphasis on AI-based dermatology therapeutics will continue to grow significantly, boosting the AI in dermatology diagnosis market growth.

Artificial Intelligence (AI) in Dermatology Diagnosis Market Geographical Outlook

• North America is witnessing exponential growth during the forecast period

This region is the global leader for several reasons, such as well-developed healthcare systems, highly mobile technology, and high investments in AI. North America has remained home to many established players and new entrants who develop AI-based dermatological solutions that promote innovation and increase the market size. In addition, the rising prevalence of skin diseases in the region and the growing demand for quick and accurate dermatological diagnosis have contributed to the increasing adoption of AI solutions in dermatology. North America's focus on technological advancements and commitment to the enhancement of dermatological care has subjugated the region in the AI in dermatology diagnosis market.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2029
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Artificial Intelligence (AI) In dermatology diagnosis market is segmented and analyzed as follows:

By Type

• Standalone AI Systems
• AI-Powered Mobile Apps

By Technology

• Machine Learning
• Deep Learning
• Computer Vision
• Natural Language Processing (NLP)
• Others

By Application

• Skin Cancer Diagnosis
• Acne And Rosacea Diagnosis
• Psoriasis Diagnosis
• Eczema Diagnosis
• Hair And Nail Disorders Diagnosis
• Others

By End-User

• Hospitals And Clinics
• Dermatology Clinics And Centers
• Research Institutes And Academic Centers
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Taiwan
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY TYPE

• 5.1. Introduction
• 5.2. Standalone AI Systems
• 5.3. AI-Powered Mobile Apps

6. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. Machine Learning
• 6.3. Deep Learning
• 6.4. Computer Vision
• 6.5. Natural Language Processing (NLP)
• 6.6. Others

7. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Skin Cancer Diagnosis
• 7.3. Acne And Rosacea Diagnosis
• 7.4. Psoriasis Diagnosis
• 7.5. Eczema Diagnosis
• 7.6. Hair And Nail Disorders Diagnosis
• 7.7. Others

8. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY END-USER

• 8.1. Introduction
• 8.2. Hospitals And Clinics
• 8.3. Dermatology Clinics and Centers
• 8.4. Research Institutes and Academic Centers
• 8.5. Others

9. ARTIFICIAL INTELLIGENCE (AI) IN DERMATOLOGY DIAGNOSIS MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. BY End-User
  • 9.2.5. By Country
    • 9.2.5.1. United States
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. South America
  • 9.3.1. By Type
  • 9.3.2. By Technology
  • 9.3.3. By Application
  • 9.3.4. BY End-User
  • 9.3.5. By Country
    • 9.3.5.1. Brazil
    • 9.3.5.2. Argentina
    • 9.3.5.3. Others
• 9.4. Europe
  • 9.4.1. By Type
  • 9.4.2. By Technology
  • 9.4.3. By Application
  • 9.4.4. BY End-User
  • 9.4.5. By Country
    • 9.4.5.1. United Kingdom
    • 9.4.5.2. Germany
    • 9.4.5.3. France
    • 9.4.5.4. Italy
    • 9.4.5.5. Spain
    • 9.4.5.6. Others
• 9.5. Middle East and Africa
  • 9.5.1. By Type
  • 9.5.2. By Technology
  • 9.5.3. By Application
  • 9.5.4. BY End-User
  • 9.5.5. By Country
    • 9.5.5.1. Saudi Arabia
    • 9.5.5.2. UAE
    • 9.5.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. By Type
  • 9.6.2. By Technology
  • 9.6.3. By Application
  • 9.6.4. BY End-User
  • 9.6.5. By Country
    • 9.6.5.1. Japan
    • 9.6.5.2. China
    • 9.6.5.3. India
    • 9.6.5.4. South Korea
    • 9.6.5.5. Indonesia
    • 9.6.5.6. Taiwan
    • 9.6.5.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. 3derm Systems, Inc.
• 11.2. Aidoc Medical Ltd.
• 11.3. Aidoc
• 11.4. Arterys Inc.
• 11.5. Beijing Infervision Technology Co., Ltd.
• 11.6. Butterfly Network, Inc.
• 11.7. Enlitic, Inc.
• 11.8. Fdna Inc.
• 11.9. Ibm Corporation
• 11.10. Mirada Medical Limited